Janney Capital Management LLC Trims Holdings in CME Group Inc. (NASDAQ:CME)

Janney Capital Management LLC lowered its holdings in CME Group Inc. (NASDAQ:CME) by 4.5% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 12,425 shares of the financial services provider’s stock after selling 591 shares during the quarter. Janney Capital Management LLC’s holdings in CME Group were worth $2,675,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. B. Riley Wealth Advisors Inc. raised its position in CME Group by 1.3% in the fourth quarter. B. Riley Wealth Advisors Inc. now owns 3,625 shares of the financial services provider’s stock valued at $782,000 after purchasing an additional 48 shares during the period. Capital Advisors Ltd. LLC raised its position in CME Group by 4.3% in the first quarter. Capital Advisors Ltd. LLC now owns 1,160 shares of the financial services provider’s stock valued at $250,000 after purchasing an additional 48 shares during the period. Lantz Financial LLC raised its position in CME Group by 1.1% in the first quarter. Lantz Financial LLC now owns 4,561 shares of the financial services provider’s stock valued at $982,000 after purchasing an additional 49 shares during the period. Transcend Capital Advisors LLC raised its position in CME Group by 1.7% in the fourth quarter. Transcend Capital Advisors LLC now owns 2,995 shares of the financial services provider’s stock valued at $631,000 after purchasing an additional 50 shares during the period. Finally, Greystone Financial Group LLC raised its holdings in shares of CME Group by 1.6% in the 4th quarter. Greystone Financial Group LLC now owns 3,282 shares of the financial services provider’s stock valued at $691,000 after buying an additional 52 shares during the period. Hedge funds and other institutional investors own 87.75% of the company’s stock.

CME Group Stock Up 0.2 %

Shares of NASDAQ:CME traded up $0.34 on Friday, hitting $196.40. 3,458,862 shares of the company’s stock were exchanged, compared to its average volume of 2,391,518. The firm’s 50-day moving average is $203.55 and its 200 day moving average is $208.14. The company has a market capitalization of $70.72 billion, a PE ratio of 22.34, a P/E/G ratio of 5.17 and a beta of 0.52. CME Group Inc. has a 1-year low of $180.11 and a 1-year high of $223.80. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.01 and a current ratio of 1.01.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, April 24th. The financial services provider reported $2.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.44 by $0.06. The business had revenue of $1.49 billion during the quarter, compared to analysts’ expectations of $1.48 billion. CME Group had a return on equity of 12.45% and a net margin of 56.84%. The business’s quarterly revenue was up 3.2% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.42 EPS. Sell-side analysts predict that CME Group Inc. will post 9.75 EPS for the current year.

CME Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Stockholders of record on Friday, June 7th were given a dividend of $1.15 per share. The ex-dividend date was Friday, June 7th. This represents a $4.60 annualized dividend and a dividend yield of 2.34%. CME Group’s dividend payout ratio is currently 52.33%.

Wall Street Analyst Weigh In

Several research firms recently issued reports on CME. Rosenblatt Securities reiterated a “sell” rating and issued a $187.00 price objective (up previously from $185.00) on shares of CME Group in a report on Thursday, April 25th. Barclays boosted their price objective on CME Group from $226.00 to $228.00 and gave the company an “equal weight” rating in a report on Thursday, April 25th. Keefe, Bruyette & Woods reiterated a “market perform” rating and issued a $226.00 price objective on shares of CME Group in a report on Wednesday. Bank of America boosted their price objective on CME Group from $209.00 to $216.00 and gave the company a “neutral” rating in a report on Thursday, April 25th. Finally, Morgan Stanley boosted their price objective on CME Group from $222.00 to $225.00 and gave the company an “equal weight” rating in a report on Tuesday, April 9th. Three investment analysts have rated the stock with a sell rating, six have given a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, CME Group presently has a consensus rating of “Hold” and an average target price of $215.90.

Insider Transactions at CME Group

In related news, insider Hilda Harris Piell sold 7,140 shares of the company’s stock in a transaction dated Wednesday, May 8th. The stock was sold at an average price of $210.35, for a total value of $1,501,899.00. Following the completion of the sale, the insider now directly owns 29,256 shares of the company’s stock, valued at approximately $6,153,999.60. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In related news, Director Charles P. Carey sold 3,000 shares of the company’s stock in a transaction dated Thursday, June 13th. The stock was sold at an average price of $195.44, for a total value of $586,320.00. Following the completion of the sale, the director now directly owns 7,163 shares of the company’s stock, valued at approximately $1,399,936.72. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Hilda Harris Piell sold 7,140 shares of the company’s stock in a transaction dated Wednesday, May 8th. The shares were sold at an average price of $210.35, for a total value of $1,501,899.00. Following the completion of the sale, the insider now directly owns 29,256 shares of the company’s stock, valued at $6,153,999.60. The disclosure for this sale can be found here. In the last ninety days, insiders sold 54,290 shares of company stock valued at $11,393,700. 0.30% of the stock is currently owned by corporate insiders.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.